IMUX RSI Chart
Last 7 days
-1.6%
Last 30 days
3.3%
Last 90 days
-0.8%
Trailing 12 Months
-29.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2021 | 0 | 0 | 0 | 17.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 26, 2024 | vitt daniel | bought | 18,333 | 1.3095 | 14,000 | president and ceo |
May 15, 2023 | whaley glenn | bought | 8,750 | 1.75 | 5,000 | chief financial officer |
Dec 14, 2022 | neermann joerg | bought | 59,032 | 1.256 | 47,000 | - |
Dec 13, 2022 | neermann joerg | bought | 43,610 | 1.246 | 35,000 | - |
Nov 23, 2022 | neermann joerg | bought | 25,020 | 1.39 | 18,000 | - |
Nov 22, 2022 | vitt daniel | bought | 10,799 | 1.3499 | 8,000 | president and ceo |
Nov 07, 2022 | whaley glenn | bought | 7,475 | 1.495 | 5,000 | chief financial officer |
Jun 03, 2022 | whaley glenn | bought | 10,657 | 3.045 | 3,500 | chief financial officer |
Jun 03, 2022 | vitt daniel | bought | 15,499 | 3.0999 | 5,000 | president and ceo |
May 12, 2022 | nash duane | gifted | - | - | -6,000 | executive chairman |
Which funds bought or sold IMUX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | new | - | 2,128,340 | 2,128,340 | 0.23% |
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 77,250 | 77,250 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 14,804 | 14,804 | -% |
May 15, 2024 | D. E. Shaw & Co., Inc. | new | - | 69,003 | 69,003 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | added | 17.57 | 7,653 | 228,780 | -% |
May 15, 2024 | RTW INVESTMENTS, LP | added | 5.36 | -473,497 | 6,029,390 | 0.09% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 803 | 49,142 | 56,208 | -% |
May 15, 2024 | BOOTHBAY FUND MANAGEMENT, LLC | added | 422 | 437,412 | 559,049 | 0.01% |
May 15, 2024 | Squarepoint Ops LLC | new | - | 41,348 | 41,348 | -% |
May 15, 2024 | Schonfeld Strategic Advisors LLC | reduced | -59.14 | -124,590 | 69,960 | -% |
Unveiling Immunic Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Immunic Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Immunic Inc News
Income Statement (Quarterly) | |||||
Description | (%) Q/Q | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
Revenue | - | - | - | - | 17,250,000 |
Operating Expenses | 18.1% | 21,721,000 | 18,387,000 | 19,170,000 | 32,387,000 |
S&GA Expenses | 15.0% | 3,343,000 | 2,907,000 | 3,432,000 | 3,618,000 |
R&D Expenses | 18.7% | 18,378,000 | 15,480,000 | 15,738,000 | 11,519,000 |
EBITDA Margin | -Infinity% | -2.40 | - | -1.20 | - |
EBT Margin | -Infinity% | -2.40 | - | -1.20 | - |
Net Income | -9.8% | -21,185,000 | -19,292,000 | -17,934,000 | -34,534,000 |
Net Income Margin | -Infinity% | -5.39 | - | - | - |
Free Cashflow | -34.5% | -23,700,000 | -17,619,000 | -29,023,000 | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 91.8% | 104 | 54.00 | 67.00 | 89.00 | 109 | 128 | 121 | 139 | 150 | 139 | 157 | 136 | 155 | 168 | 172 | 87.00 | 57.00 | 66.00 | 68.00 | 73.00 | 10.00 |
Current Assets | 95.3% | 103 | 53.00 | 65.00 | 87.00 | 107 | 126 | 87.00 | 105 | 116 | 105 | 122 | 102 | 120 | 134 | 138 | 53.00 | 24.00 | 32.00 | 35.00 | 39.00 | 10.00 |
Cash Equivalents | 108.5% | 97.00 | 47.00 | 60.00 | 77.00 | 93.00 | 107 | 73.00 | 88.00 | 96.00 | 87.00 | 110 | 87.00 | 115 | 127 | 133 | 49.00 | 19.00 | 29.00 | 30.00 | 36.00 | 8.00 |
Net PPE | -5.2% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 |
Liabilities | -18.9% | 21.00 | 25.00 | 19.00 | 19.00 | 18.00 | 14.00 | 12.00 | 11.00 | 12.00 | 12.00 | 11.00 | 15.00 | 17.00 | 9.00 | 9.00 | 8.00 | 7.00 | 8.00 | 7.00 | 3.00 | - |
Current Liabilities | -18.5% | 20.00 | 25.00 | 18.00 | 18.00 | 16.00 | 13.00 | 12.00 | 10.00 | 11.00 | 11.00 | 11.00 | 14.00 | 16.00 | 8.00 | 8.00 | 8.00 | 6.00 | 7.00 | 7.00 | 3.00 | 1.00 |
Shareholder's Equity | 188.9% | 84.00 | 29.00 | 48.00 | 69.00 | 91.00 | 114 | 109 | 128 | 138 | 127 | 145 | 121 | 137 | 159 | 163 | 79.00 | 50.00 | 58.00 | 61.00 | 69.00 | 9.00 |
Retained Earnings | -7.2% | -440 | -410 | -389 | -366 | -342 | -317 | -260 | -239 | -217 | -196 | -175 | -156 | -138 | -103 | -92.80 | -79.90 | -68.40 | -59.91 | -52.22 | -44.00 | -346 |
Additional Paid-In Capital | 19.2% | 520 | 436 | 434 | 432 | 430 | 428 | 370 | 368 | 356 | 324 | 322 | 279 | 277 | 267 | 257 | 160 | 121 | 120 | 115 | 114 | 356 |
Shares Outstanding | 99.4% | 90.00 | 45.00 | 45.00 | 44.00 | 44.00 | 39.00 | 31.00 | 29.00 | 28.00 | 26.00 | 22.00 | 21.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 110 | - | - | - | 106 | - | - | - | 225 | - | - | - | 181 | - | - | - | 51.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -70.9% | -23,969 | -14,027 | -17,312 | -19,976 | -19,513 | -15,104 | -13,596 | -15,763 | -20,681 | -23,681 | -17,599 | -29,005 | -12,948 | -13,963 | -11,905 | -9,227 | -11,029 | -6,265 | -5,976 | -10,987 | -5,317 |
Share Based Compensation | 67.9% | 2,750 | 1,638 | 1,687 | 1,798 | 1,979 | 1,886 | 1,912 | 2,062 | 2,069 | 1,466 | 1,397 | 1,507 | 1,579 | 1,318 | 707 | 369 | 353 | 330 | 199 | 5,983 | - |
Cashflow From Investing | 81.2% | -31.00 | -165 | -44.00 | 4,336 | 5,335 | -9,628 | -73.00 | -28.00 | -12.00 | -19.00 | -20.00 | -18.00 | -10.00 | -24.00 | -63.00 | -55.00 | -4.00 | -25.00 | 1,237 | 9,331 | -7.00 |
Cashflow From Financing | 12228.5% | 74,464 | 604 | 282 | 96.00 | 51.00 | 56,041 | - | 10,076 | 29,643 | 821 | 42,020 | - | - | 8,111 | 96,540 | 39,212 | 568 | 4,707 | 223 | 9,434 | 20,531 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 18,736 | $ 22,963 |
General and administrative | 5,145 | 4,288 |
Total operating expenses | 23,881 | 27,251 |
Loss from operations | (23,881) | (27,251) |
Other income (expense): | ||
Interest income | 1,187 | 800 |
Change in fair value of the tranche rights | (4,796) | 0 |
Other income (expense), net | (2,094) | 1,179 |
Total other income (expense) | (5,703) | 1,979 |
Net loss | $ (29,584) | $ (25,272) |
Net loss per share, basic (in USD per share) | $ (0.30) | $ (0.58) |
Net loss per share, diluted (in USD per share) | $ (0.30) | $ (0.58) |
Weighted-average common shares outstanding, basic (in shares) | 97,299,955 | 43,664,783 |
Weighted-average common shares outstanding, diluted (in shares) | 97,299,955 | 43,664,783 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 97,312 | $ 46,674 |
Other current assets and prepaid expenses | 5,303 | 5,860 |
Total current assets | 102,615 | 52,534 |
Property and equipment, net | 442 | 466 |
Right-of-use assets, net | 1,098 | 1,299 |
Total assets | 104,155 | 54,299 |
Current liabilities: | ||
Accounts payable | 6,767 | 5,099 |
Accrued expenses | 12,419 | 18,664 |
Other current liabilities | 960 | 966 |
Total current liabilities | 20,146 | 24,729 |
Long-term liabilities | ||
Operating lease liabilities | 433 | 639 |
Total long-term liabilities | 433 | 639 |
Total liabilities | 20,579 | 25,368 |
Commitments and contingencies (Note 4) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value; 20,000,000 authorized and no shares issued or outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.0001 par value; 500,000,000 and 130,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively, and 90,079,016 and 45,177,730 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 8 | 4 |
Additional paid-in capital | 519,757 | 436,060 |
Accumulated other comprehensive income | 4,287 | 3,759 |
Accumulated deficit | (440,476) | (410,892) |
Total stockholders’ equity | 83,576 | 28,931 |
Total liabilities and stockholders’ equity | $ 104,155 | $ 54,299 |